A NEW ERA IN SEPSIS DIAGNOSTICS

Ultrafast pathogen identification
directly from blood

No culture. No labeling.
Advanced sensing enhanced by AI to support life-saving clinical decisions.

sepsis

A life-threatening emergency where every minute counts

Sepsis is the body’s extreme response to infection, which can rapidly lead to organ failure and death within hours. Traditional diagnostics take days to identify the pathogen, so treatment often starts without knowing the exact cause, delaying targeted therapy when time is critical.

There is an urgent need for a fast and accurate ID test.

+8% mortality per hour

2-5 days for pathogen ID

11 million deaths per year

REAL IMPACT

Bacterial ID in minutes for early intervention

Powered by optomechanical sensing and AI, SOMIA delivers accurate results directly from blood, without the need for culture or labeling.

It identifies the pathogen within minutes, enabling targeted treatment from the first hour and increasing patient survival by up to 80%.

< 30 minutes to results

Culture-free and label-free

Pathogen ID even at low concentrations

High sensitivity and specificity

SOMIA IN ACTION

Compact. Simple. Effective.

A compact, easy-to-use diagnostic platform designed for real-time sepsis detection at the point of care.

SOMIA integrates smoothly into clinical workflows, delivering fast and reliable results with minimal user intervention. From sample to answer in just a few steps.

Easy sample insertion
Whole blood is loaded directly into a disposable cartridge.

Automated preparation
Integrated microfluidics isolate bacteria from the sample. No manual pretreatment required.

Real-time biophysical sensing
Laser-based analysis profiles individual cells by mass, size and optical absorbance.

Accurate AI-powered ID
Deep learning algorithms identify pathogens within minutes, with high sensitivity and specificity.

ABOUT US

From research excellence to clinical innovation

Nanological is a Deep Tech diagnostics company born out of the Spanish National Research Council (CSIC), Spain’s largest public research institution.

Its proprietary platform builds on more than a decade of pioneering research in optomechanical biosensing, supported by peer-reviewed publications and protected by international patents.

Backed by a strong scientific foundation, Nanological brings together scientists, engineers, clinicians, and business professionals committed to turning scientific breakthroughs into real-world clinical solutions.